In this free webinar, attendees will gain insights into novel methodologies for precise and efficient DNA and RNA synthesis. Attendees will learn about nucleic acids beyond genetic encoding, including catalytic RNAs and nucleic acid-based nanostructures. The featured speaker will discuss the role of nucleic acid-based drugs in modern medicine, including mRNA vaccines and siRNA therapies. The speaker will also share how advancements in nucleic acid chemistry connect different scientific and medical domains.
TORONTO, March 13, 2025 /PRNewswire-PRWeb/ -- The field of nucleic acid chemistry has witnessed remarkable advancements in recent years, revolutionizing our understanding of synthesis, functionality and therapeutic applications. This webinar will explore the cutting-edge developments that are shaping the future of this dynamic discipline.
The expert speakers will begin by delving into the latest breakthroughs in nucleic acid synthesis, including novel methodologies for the efficient and precise construction of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) molecules. These innovations not only enhance our ability to manipulate genetic material but also pave the way for the creation of synthetic nucleic acids with tailored properties.
Next, they will examine the functional aspects of nucleic acids, focusing on their roles beyond traditional genetic encoding. From catalytic RNAs to nucleic acid-based nanostructures, they will highlight how these molecules are being engineered to perform diverse biological and chemical functions, opening new avenues for research and application.
Finally, the presentation will address the transformative impact of nucleic acid chemistry on therapeutic development. They will discuss the emergence of nucleic acid-based drugs, such as mRNA vaccines, siRNA therapies and CRISPR-based gene editing tools, which are revolutionizing medicine by offering targeted and personalized treatment options.
By bridging the gaps between synthesis, function and therapeutic application, this presentation will underscore the pivotal role of nucleic acid chemistry in driving innovation across multiple scientific and medical domains.
Register for this webinar to explore the frontiers of nucleic acid chemistry and its potential to shape the future of biotechnology and healthcare.
Join Dr. Jinsen Chen, Executive Director of Nucleic Acid Chemistry, HitGen Inc., and Dr. Minghong Zhong, CEO, GeneLancet Biosciences Inc. for the live webinar on Monday, March 31, 2025, at 11am EDT (5pm CEST/EU-Central).
For more information, or to register for this event, visit Innovations in Nucleic Acid Chemistry: Bridging Synthesis, Function and Therapeutic Frontiers.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], https://xtalks.com
SOURCE Xtalks
Share this article